isradipine


Also found in: Medical, Wikipedia.
Related to isradipine: Calcium channel blockers
Translations

isradipine

n isradipino, isradipina
References in periodicals archive ?
Calcium channel blocking as a therapeutic strategy for Alzheimer's disease: The case for isradipine. Biochim Biophys Acta 2011;1812:1584-90.
Agents currently under investigation are anti-apoptotics (Omigapil), anti-glutamatergics, monoamine oxidase inhibitors (Selegiline), promitochondrials (Coenzyme Q10, creatine), calcium channel blockers (Isradipine) and growth factors (GDNF).
Effects of isradipine, a dihydropyridine-class calcium channel antagonist, on D-methamphetamine-induced cognitive and physiological changes in humans.
Interestingly, isradipine inhibits palatability induced polydipsia, but deprivation induced polydipsia is unaffected (showing the role of L-type [Ca.sup.++] channels in dopaminergic pleasure performances).
Last year saw the company launch trandolapril tablets, USP; hydroxyzine hydrochloride tablets, USP; meperidine hydrochloride tablets (CII); and isradipine capsules, USP.
LLC, Bridgewater, NJ, USA); Zofran (GlaxoSmithKline, Philadelphia, PA, USA); Phenergan (Wyeth, Madison, NJ, USA); Tylenol (Johnson & Johnson, New Brunswick, NJ, USA); albuterol; isradipine; Spironolactone (Mylan Pharmaceuticals, Morgantown, WV, USA); hemotransfusion; and platelet transfusion.
[129] have studied the dose-dependent (1, 5, 10, and 50 [micro]M) AOA of various CA (verapamil, diltiazem, and DHPs: nifedipine, amlodipine, isradipine, or lacidipine) against normolipidemic human blood LDL oxidation compared with [alpha]-tocopherol by measuring the content of TBARS and the diene formation (see Table 4).
The company said the increase in fiscal 2015 revenues is due to the continued growth and expansion of its generic product lines, with the launch of Isradipine 2.5 mg and 5.0 mg capsules during Fiscal 2015.
Fox Foundation, says a vaccine against a protein, a blood-pressure drug called isradipine, and a supplement, inosine, looked promising in clinical trials.
But a few other substances -- a vaccine against a protein called alpha-synuclein, a blood pressure drug called isradipine, and inosine, a supplement that raises urate levels -- are showing promise in clinical trials.